Ellsworth Advisors’s GeneDx Holdings WGS Stock Holding History

Ellsworth Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15,965	Closed	-$1.41M	–	197
2025 Q1	$1.41M	Buy	+15,965	New	+$1.39M	0.37%	82

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Ellsworth Advisors's WGS Position: Q2 2025 in Review

Ellsworth Advisors sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 15,965 shares — an estimated $1.41M sold.

Ellsworth Advisors first reported a position in WGS in Q1 2025 and held it in 1 quarter. The position peaked at $1.41M in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

Ellsworth Advisors reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
Ellsworth Advisors sold 15,965 GeneDx Holdings shares in Q2 2025, an estimated $1.41M.
Ellsworth Advisors first reported a position in GeneDx Holdings in Q1 2025 and held it in 1 quarter.
Ellsworth Advisors's GeneDx Holdings position peaked at $1.41M in Q1 2025.
231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Ellsworth Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.